TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 12.23%12.98B | -10.12%24.97B | -14.94%11.56B | 16.51%27.78B | 19.56%13.59B | 3.54%23.85B | 11.09%11.37B | 1.61%23.03B | -0.45%10.23B | 8.19%22.67B |
Operating income | 12.23%12.98B | -10.12%24.97B | -14.94%11.56B | 16.51%27.78B | 19.56%13.59B | 3.54%23.85B | 11.09%11.37B | 1.61%23.03B | -0.45%10.23B | 8.19%22.67B |
Cost of sales | -2.76%-9.21B | 12.68%-18.91B | 14.82%-8.97B | -19.94%-21.66B | -31.65%-10.53B | -14.01%-18.06B | -13.02%-8B | -0.30%-15.84B | 0.42%-7.08B | -10.14%-15.79B |
Operating expenses | -2.76%-9.21B | 12.68%-18.91B | 14.82%-8.97B | -19.94%-21.66B | -31.65%-10.53B | -14.01%-18.06B | -13.02%-8B | -0.30%-15.84B | 0.42%-7.08B | -10.14%-15.79B |
Gross profit | 44.96%3.76B | -1.08%6.06B | -15.35%2.59B | 5.81%6.13B | -9.09%3.07B | -19.53%5.79B | 6.76%3.37B | 4.63%7.19B | -0.51%3.16B | 3.96%6.88B |
Selling expenses | -4.56%-84.84M | 19.63%-164.16M | 34.95%-81.14M | 11.83%-204.25M | -68.73%-124.74M | -55.81%-231.66M | 2.18%-73.93M | 60.86%-148.68M | 65.97%-75.58M | 46.39%-379.84M |
Administrative expenses | -3.28%-943.7M | 3.75%-1.88B | 8.85%-913.69M | 1.21%-1.95B | -5.15%-1B | -20.73%-1.98B | -16.68%-953.36M | -5.68%-1.64B | -2.14%-817.07M | -6.96%-1.55B |
Operating interest expense | ---- | ---- | ---- | ---- | -101.08%-103.56M | -33.06%-144.04M | 18.07%-51.5M | -21.39%-108.25M | ---62.86M | -46.08%-89.18M |
Special items of operating profit | -20.24%705.1M | -14.93%1.31B | -5.96%884.05M | 305.87%1.54B | 305.30%940.05M | 83.65%380.6M | -59.46%231.94M | -70.79%207.24M | 15.68%572.07M | 2.77%709.53M |
Operating profit | 38.40%3.44B | -3.33%5.33B | -10.48%2.48B | 44.44%5.51B | 9.89%2.77B | -30.69%3.82B | -9.00%2.53B | -1.07%5.51B | 4.83%2.78B | 9.45%5.57B |
Financing cost | -30.86%-191.39M | -51.43%-345.81M | ---146.26M | ---228.36M | ---- | ---- | ---- | ---- | ---- | ---- |
Share of profits of associates | -75.74%2.56M | 159.98%12.84M | 261.29%10.55M | -394.67%-21.4M | -235.10%-6.54M | 15.84%7.26M | 74.33%4.84M | 7.81%6.27M | -1.35%2.78M | 13.57%5.82M |
Earning before tax | 38.36%3.25B | -5.07%5B | -15.17%2.35B | 37.63%5.26B | 9.42%2.77B | -30.64%3.82B | -8.92%2.53B | -1.06%5.51B | 6.28%2.78B | 9.46%5.57B |
Tax | -43.59%-318.18M | 37.30%-438.24M | 44.70%-221.6M | -54.75%-698.91M | -31.68%-400.72M | -5.09%-451.64M | -5.32%-304.33M | 29.91%-429.78M | -4.19%-288.96M | -2.58%-613.21M |
After-tax profit from continuing operations | 37.81%2.93B | -0.13%4.56B | -10.17%2.13B | 35.34%4.56B | 6.37%2.37B | -33.66%3.37B | -10.57%2.23B | 2.50%5.08B | 6.52%2.49B | 10.37%4.96B |
Earning after tax | 37.81%2.93B | -0.13%4.56B | -10.17%2.13B | 35.34%4.56B | 6.37%2.37B | -33.66%3.37B | -10.57%2.23B | 2.50%5.08B | 6.52%2.49B | 10.37%4.96B |
Minority profit | ---- | ---- | ---- | 1,760.87%382K | 342.73%1.07M | 99.90%-23K | 98.12%-440K | 82.37%-24.09M | 70.53%-23.42M | -185.06%-136.67M |
Profit attributable to shareholders | 37.81%2.93B | -0.12%4.56B | -10.13%2.13B | 35.33%4.56B | 6.30%2.37B | -33.98%3.37B | -11.39%2.23B | 0.23%5.11B | 3.99%2.51B | 12.22%5.1B |
Basic earnings per share | 38.30%1.95 | -0.33%3.03 | -10.19%1.41 | 35.71%3.04 | 6.08%1.57 | -34.12%2.24 | -11.38%1.48 | 0.29%3.4 | 3.73%1.67 | 12.25%3.39 |
Diluted earnings per share | 38.30%1.95 | -0.33%3.03 | -10.19%1.41 | 35.71%3.04 | 6.08%1.57 | -34.12%2.24 | 1.48 | 0.29%3.4 | 12.25%3.39 | |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.